Followers | 199 |
Posts | 17219 |
Boards Moderated | 2 |
Alias Born | 02/17/2012 |
Tuesday, August 04, 2020 1:04:06 PM
ALXO
What we've got here...is failure to communicate. Some men you just can't reach...which is the way he wants it, well, HE GETS IT! And I dont like it anymore than you men.
*Contact your licensed financial advisor before entering the market.
Recent ALXO News
- ALX Oncology to Present at the 2024 Cantor Fitzgerald Global Healthcare Conference • GlobeNewswire Inc. • 09/09/2024 12:00:00 PM
- ALX Oncology Announces First Patients Dosed with Evorpacept and Sarclisa As Part of Randomized Phase 1/2 UMBRELLA Study with Sanofi • GlobeNewswire Inc. • 09/04/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 09:10:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 09:09:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 09:06:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:03:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:08:01 PM
- ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/08/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 09:23:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 09:22:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:45:02 PM
- ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors • GlobeNewswire Inc. • 08/06/2024 08:01:00 PM
- ALX Oncology Reports Topline Data From ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Improves Tumor Response in Patients With HER2-Positive Gastric Cancer • GlobeNewswire Inc. • 07/31/2024 08:01:00 PM
- ALX Oncology to Host Investor Call and Webcast to Share Topline Data Results From ASPEN-06 Phase 2 Clinical Trial of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer • GlobeNewswire Inc. • 07/31/2024 09:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:06:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 08:23:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:09:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:21:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:06:22 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/04/2024 08:14:18 PM
- ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer • GlobeNewswire Inc. • 06/02/2024 02:00:00 PM
- ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/29/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 08:30:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2024 08:06:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:10:53 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM